DNA-Encoded Libraries in Drug Discovery: How Amgen Uses DEL Technology to Find New Medicines
See how Amgen scientists use DNA Encoded Library (DEL) technology to search through vast numbers of potential medicines – 10,000 times more than traditional screening methods. By tagging up to a trillion compounds with unique DNA barcodes, scientists can identify molecules that bind to disease targets and uncover new possibilities for treatment. DEL technology helps Amgen tackle challenging diseases once thought impossible to target and accelerates the discovery of small-molecule drug candidates. Learn more at: https://wwwext.amgen.com/stories/2025... #Amgen #DNA #DrugDiscovery #DNAEncodedLibraries #Biotechnology Find Amgen on the Web: Facebook: https://bit.ly/35Xf09E Instagram: https://bit.ly/2SYnTKJ Twitter: https://bit.ly/2SW2cLq LinkedIn: https://bit.ly/2xWbS17
The Evolution of Biotechnology – The Arrival of Biosimilars
Omics in Drug Discovery: How Amgen Uses Omics to Understand Disease
AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research
IgG4-RD Explained: From Delayed Diagnosis to Improving Care
Inside Amgen’s Next-Generation Labs | Faster, Smarter Small Molecule Drug Discovery
Advancing Obesity Research
AI in Drug Discovery: How Amgen Uses AI to Design Proteins
How Biosimilars Are Made: Inside Biologic Drug Manufacturing
